TL;DR
Insights from proteomics in ovarian, breast, and colon cancers mark a era of transformation, offering personalized cancer care and improved clinical outcomes, as propelled by advanced technologies like LC-MS/MS and iTRAQ.
AI-generated by Semantic Scholar
